NCT03463785

Brief Summary

Obstructive sleep apnea (OSA) is a sleep-related breathing disorder, often associated with a compromised upper airway space and an increase in upper airway collapsibility. The anatomical and functional abnormalities of the upper airway play an important role in the pathogenesis of OSA. It is hypothesized that there is racial variation in the craniofacial characteristics among OSA patients. However, inter-race comparisons based on previous studies can be problematic due to variation in measurements, OSA definitions and the sample size. Besides, to our best knowledge, there is no studies that made direct inter-race comparisons in the upper airway anatomy. Therefore, studies on inter-race comparisons of the upper airway characteristics are needed to further understand the role of race in the upper airway anatomy of the OSA patients. This would provide more insights into the pathophysiology of OSA, and could result in the development of new effective treatment strategies for OSA patients.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2017

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 13, 2018

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 29, 2025

Status Verified

January 1, 2025

Enrollment Period

7.7 years

First QC Date

March 7, 2018

Last Update Submit

January 27, 2025

Conditions

Keywords

obstructive sleep apnearaceupper airwaycone beam computed tomography

Outcome Measures

Primary Outcomes (1)

  • the minimum cross-sectional area of the upper airway

    measurement of the smallest area on the cross-sectional plane

    within a week after taking CBCT scan of the patient

Secondary Outcomes (4)

  • the anterior-posterior dimension of CSAmin

    within a week after taking CBCT scan of the patient

  • the lateral dimension of CSAmin

    within a week after taking CBCT scan of the patient

  • the volume of the upper airway

    within a week after taking CBCT scan of the patient

  • the length of the upper airway

    within a week after taking CBCT scan of the patient

Study Arms (2)

Chinese

Chinese mild or moderate OSA patients

Other: cone beam computed tomography

Dutch

Dutch mild or moderate OSA patients

Other: cone beam computed tomography

Interventions

The CBCT data sets of both the Chinese and Dutch OSA patients will be obtained using a NewTom 5G CBCT system (QR systems, Verona, Italy), according to the standard imaging protocol. The OSA patients will be treated with mandibular advancement device.

Also known as: Mandibular advancement device (MAD)
ChineseDutch

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

the mild or moderate OSA patients with different racial background

You may qualify if:

  • years and older;
  • Ability to speak, read, and write Dutch/Chinese;
  • Ability to follow-up;
  • Ability to use a computer with internet connection for online questionnaires;
  • Diagnosis with symptomatic mild or moderate OSA (5 ≤ apnea-hypopnea index (AHI) \< 30);
  • Expected to maintain current lifestyle (sports, medicine, diet, etc.).

You may not qualify if:

  • Untreated periodontal problems, dental pain, and a lack of retention possibilities for a MAD;
  • Medication used/related to sleeping disorders;
  • Evidence of respiratory/sleep disorders other than OSA (eg. central sleep apnea syndrome);
  • Systemic disorders (based on medical history and examination; e.g. rheumatoid arthritis);
  • Temporomandibular disorders (based on the function examination of the masticatory system);
  • Medical history of known causes of tiredness by day, or severe sleep disruption (Insomnia, PLMS, Narcolepsy);
  • Known medical history of mental retardation, memory disorders, or psychiatric disorders.
  • Reversible morphological upper airway abnormalities (e.g. enlarged tonsils);
  • Inability to provide informed consent;
  • simultaneous use of other modalities to treat OSA;
  • Previous treatment with a MAD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Dentistry

Jinan, Shandong, 250012, China

Location

Dentistry

Amsterdam, 4081LA, Netherlands

Location

Related Publications (1)

  • Shi X, Chen H, Lobbezoo F, de Lange J, van der Stelt P, Berkhout E, Guo J, Ge S, Li G, Li Y, Aarab G. Comparison of the upper airway morphology between Dutch and Chinese adults with obstructive sleep apnea. Sleep Breath. 2023 Dec;27(6):2223-2230. doi: 10.1007/s11325-023-02834-z. Epub 2023 Apr 24.

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Occlusal Splints

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Orthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and Supplies

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

March 7, 2018

First Posted

March 13, 2018

Study Start

May 1, 2017

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 29, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

all collected IPD, all IPD that underlie results in a publication will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After the papers are accepted.
Access Criteria
The data will be shared with the researchers, who is interested in our project. The types of analyses used in the projected will be share via email to the corresponding authors.

Locations